Missing Work Is a Pain

References

1. 1. Autor David

   . 2003. “Outsourcing at Will: The Contribution of Unjust Dismissal Doctrine to the Growth of Employment Outsourcing.” Journal of Labor Economics 21(1):1–42.

   OpenUrlCrossRefWeb of Science
2. 1. Bailey Martha

   . 2006. “More Power to the Pill: The Impact of Contraceptive Freedom on Women’s Life Cycle Labor Supply.” The Quarterly Journal of Economics 121(1):289–320.

   OpenUrlCrossRefWeb of Science
3. 1. Bailey Martha,
   2. Goodman-Bacon Andrew

   . 2015. “The War on Poverty’s Experiment in Public Medicine: The Impact of Community Health Centers on the Mortality of Older Americans.” American Economic Review 105(3):1067–1104.

   OpenUrlCrossRefPubMed
4. 1. Barmby Tim,
   2. Ercolani Marco,
   3. Treble John

   . 2002. “Sickness Absence: An International Comparison.” The Economic Journal 112(480):F315–31.

   OpenUrl
5. 1. Black Sandra,
   2. Devereux Paul,
   3. Salvanes Kjell

   . 2005. “The More the Merrier? The Effect of Family Size and Birth Order on Children’s Education.” The Quarterly Journal of Economics 120(2):669–700.

   OpenUrlCrossRefWeb of Science
6. 1. Black Sandra,
   2. Devereux Paul,
   3. Salvanes Kjell

   . 2015. “Losing Heart? The Effect of Job Displacement on Health.” Industrial Labor Relations Review 68(4):833–61.

   OpenUrlCrossRef
7. 1. Bloom David,
   2. Canning David,
   3. Sevilla Jaypee

   . 2004. “The Effect of Health on Economic Growth: A Production Function Approach.” World Development 32(1):1–13.

   OpenUrlCrossRefWeb of Science
8. 1. Börsch-Supan Axel

   . 2007. “Work Disability, Health, and Incentive Effects.” Mannheim Research Institute for the Economics of Aging (MEA) Discussion Paper #135. Mannheim University, Germany.
9. 1. Bratberg Espen,
   2. Dahl Svenn-Åge,
   3. Risa Alf Erling

   . 2002. “‘The Double Burden’: Do Combinations of Career and Family Obligations Increase Sickness Absence Among Women?” European Sociological Review 18(2):233–49.

   OpenUrlCrossRefWeb of Science
10. 1. Brekke Kurt,
    2. Holmas Tor Helge,
    3. Straume Odd Rune

    . 2011. “Reference Pricing, Competition, and Pharmaceutical Expenditures: Theory and Evidence from a Natural Experiment.” Journal of Public Economics 95(7–8):624–38.

    OpenUrl
11. 1. Bresalier Robert,
    2. Sandler Robert,
    3. Quan Hui,
    4. Bolognese James,
    5. Oxenius Bettina,
    6. Horgan Kevin,
    7. Lines Christopher,
    8. et al

    . 2005. “Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial.” New England Journal of Medicine 352(11):1092–1102.

    OpenUrlCrossRefPubMedWeb of Science
12. 1. Chintagunta Pradeep,
    2. Jiang Renna,
    3. Jin Ginger

    . 2009. “Information, Learning, and Drug Diffusion: The Case of Cox-2 Inhibitors.” Quantitative Marketing and Economics 7(4):399–443.

    OpenUrl
13. 1. Collins Michael,
    2. Simon Kosali,
    3. Tennyson Sharon

    . 2013. “Drug Withdrawals and the Utilization of Therapeutic Substitutes: The Case of Vioxx.” Journal of Economic Behavior and Organization 86:148–68.

    OpenUrl
14. 1. Currie Janet,
    2. Madrian Brigitte

    . 1999. “Health, Health Insurance and the Labor Market.” In Handbook of Labor Economics, Volume 3, ed. Ashenfelter Orley, Card David, 3309–3416. Amsterdam, North Holland.

    OpenUrlCrossRef
15. 1. Duratovic Sabina

    . 2007. “En Analyse av Rofekoksib-Brukere i Norge Før og Etter Tilbake-trekningen av Rofekoksib (Vioxx) fra Verdensmarkedet: En Reseptregisterstudie.” University of Oslo Master’s Thesis.
16. 1. Epstein Andrew,
    2. Groeneveld Peter,
    3. Harhay Michael,
    4. Yang Feifei,
    5. Polsky Daniel

    . 2013. “Impact of Minimally Invasive Surgery on Medical Spending and Employee Absenteeism.” Journal of the American Medical Association Surgery 148(7):641–7.

    OpenUrl
17. 1. Eriksen Stein Anders,
    2. Nilsen Jan Ståle,
    3. Spigset Olav,
    4. Slørdal Lars

    . 2003. “Selektive COX-2-Hemmere: Holdninger og Forskrivningspraksis Blant Allmennpraktikere.” Tidsskrift for Den Norske Legeforening 123(10):1334–7.

    OpenUrl
18. 1. Garthwaite Craig

    . 2012. “The Economic Benefits of Pharmaceutical Innovations: The Case of Cox-2 Inhibitors.” American Economic Journal: Applied Economics 4(3):116–37.

    OpenUrl
19. 1. Gaskin Darrell,
    2. Richard Patrick

    . 2012. “The Economic Costs of Pain in the United States.” The Journal of Pain 13(8):715–24.

    OpenUrlCrossRefPubMed
20. 1. Gjesdal Sturla,
    2. Ringdal Peder,
    3. Haug Kjell,
    4. Mæland John Gunnar

    . 2004. “Predictors of Disability Pension in Long-Term Sickness Absence: Results from a Population-Based and Prospective Study in Norway 1994–1999.” European Journal of Public Health 14(4):398–405.

    OpenUrlCrossRefPubMedWeb of Science
21. 1. Goldin Claudia,
    2. Katz Lawrence

    . 2002. “The Power of the Pill: Oral Contraceptives and Women’s Career and Marriage Decisions.” Journal of Political Economy 110(4):730–70.

    OpenUrlCrossRefWeb of Science
22. 1. Griffin Marie

    . 2000. “The Cox-2 Report: The Good, the Bad, and the Unknown.” Journal of Clinical Outcomes Management 7(1):62–6.

    OpenUrl
23. 1. Hansen George,
    2. Streltzer Jon

    . 2005. “The Psychology of Pain.” Emergency Medicine Clinics of North America 23(2):339–48.

    OpenUrlCrossRefPubMed
24. 1. Imbens Guido

    . 2015. “Matching Methods in Practice: Three Examples.” Journal of Human Resources 50(2):373–419.

    OpenUrlAbstract/FREE Full Text
25. 1. Jacobson Louis,
    2. LaLonde Robert,
    3. Sullivan Daniel

    . 1993. “Earnings Losses of Displaced Workers.” American Economic Review 83(4):685–709.

    OpenUrlWeb of Science
26. 1. Johannes Catherine,
    2. Kim Le T.,
    3. Zhou Xiaolei,
    4. Johnston Joseph,
    5. Dworkin Robert

    . 2010. “The Prevalence of Chronic Pain in United States Adults: Results of an Internet-Based Survey.” Journal of Pain 11(11):1230–9.

    OpenUrlCrossRefPubMedWeb of Science
27. 1. Kapteyn Arie,
    2. Smith James,
    3. van Soest Arthur

    . 2008. “Dynamics of Work Disability and Pain.” Journal of Health Economics 27(2):496–509.

    OpenUrlCrossRefPubMedWeb of Science
28. 1. Kostøl Andreas,
    2. Mogstad Magne

    . 2014. “How Financial Incentives Induce Disability Insurance Recipients to Return to Work.” American Economic Review 104(2):624–55.

    OpenUrlCrossRef
29. 1. Markussen Simen

    . 2009. “Closing the Gates? Evidence from a Natural Experiment on Physicians’ Sickness Certification.” Memorandum No. 19/2009. Department of Economics, University of Oslo.
30. 1. Markussen Simen

    . 2012. “The Individual Cost of Sick Leave.” Journal of Population Economics 25 (4):1287–1306.

    OpenUrlCrossRef
31. 1. Markussen Simen,
    2. Mykletun Arnstein,
    3. Røed Knut

    . 2012. “The Case for Presenteeism-Evidence from Norway’s Sickness Insurance Program.” Journal of Public Economics 96(11–12):959–72.

    OpenUrl
32. 1. Markussen Simen,
    2. Røed Knut,
    3. Røgeberg Ole,
    4. Gaure Simen

    . 2011. “The Anatomy of Absenteeism.” Journal of Health Economics 30(2):277–92.

    OpenUrlCrossRefPubMedWeb of Science
33. 1. Mastekaasa Amy

    . 2000. “Parenthood, Gender and Sickness Absence.” Social Science & Medicine 50(12):1827–42.

    OpenUrlCrossRefPubMed
34. 1. Mitchell Jean

    . 1991. “Work Behavior after the Onset of Arthritis.” Medical Care 29(4):362–76.

    OpenUrlCrossRefPubMedWeb of Science
35. 1. Mitchell Jean,
    2. Burkhauser Richard

    . 1990. “Disentangling the Effect of Arthritis on Earnings: A Simultaneous Estimate of Wage Rates and Hours Worked.” Applied Economics 22(10):1291–1309.

    OpenUrlCrossRefWeb of Science
36. 1. Møen Jarle,
    2. Salvanes Kjell,
    3. Sørensen Erik

    . 2003. “Documentation of the Linked Employer-Employee Data Base at the Norwegian School of Economics.” The Norwegian School of Economics. Unpublished.
37. 1. Mukherjee Debabrata,
    2. Nissen Steven,
    3. Topol Eric

    . 2001. “Risk of Cardiovascular Events Associated with Selective Cox-2 Inhibitors.” Journal of the American Medical Association 286 (8):954–9.

    OpenUrlCrossRefPubMedWeb of Science
38. 1. Nichol Kristin

    . 2001. “Cost-Benefit Analysis of a Strategy to Vaccinate Healthy Working Adults Against Influenza.” Archives of Internal Medicine 161(5):749–59.

    OpenUrlCrossRefPubMedWeb of Science
39. 1. Nichol Kristin,
    2. Heilly Sarah,
    3. Greenberg Michael,
    4. Ehlinger Edward

    . 2009. “Burden of Influenza-Like Illness and Effectiveness of Influenza Vaccination Among Working Adults Aged 50–64 Years.” Clinical Infectious Diseases 48(3):292–8.

    OpenUrlCrossRefPubMedWeb of Science
40. 1. Papageorge Nicholas W.

    2016. “Why Medical Innovation is Valuable: Health, Human Capital, and the Labor Market.” Quantitative Economics 7(3):671–725.

    OpenUrl
41. 1. Rege Mari,
    2. Telle Kjetil,
    3. Votruba Mark

    . 2009. “The Effect of Plant Downsizing on Disability Pension Utilization.” Journal of the European Economic Association 7(4):754–85.

    OpenUrlCrossRefWeb of Science
42. 1. Rho Hye Jin

    . 2010. “Hard Work? Patterns in Physically Demanding Labor Among Older Workers.” Washington, DC: Center for Economic and Policy Research. Unpublished.
43. 1. Rieck Karsten,
    2. Vaage Kjell

    . 2012. “Social Interactions at the Workplace: Exploring Sickness Absence Behavior.” Working Papers in Economics No. 11/12, University of Bergen, Department of Economics.
44. 1. Rognstad Sture,
    2. Straand Jørund

    . 2006. “Hvordan Opplevde Pasientene Tilbaketrekkingen av Vioxx?” Tidsskrift for Den Norske Legeforening 126(10):1326–27.

    OpenUrl
45. 1. Rubin Rita

    . 2004. “Merck Halts Vioxx Sales.” USA Today, September 30.
46. 1. Rugstad Hans Erik

    . 2000. “COX-2-Hemmere.” Tidsskrift for Den Norske Legeforening 120(12):1398.

    OpenUrl
47. 1. Rugstad Hans Erik,
    2. Giercksky Karl Erik,
    3. Husby Gunnar,
    4. Holme Ingar

    . 1994. “Effect of Cimetidine on Gastrointestinal Symptoms in Patients Taking Nonsteroidal Anti-Inflammatory Drugs: A Large Double-Blind Placebo Controlled Study.” Scandinavian Journal of Rheumatology 23(4):177–82.

    OpenUrlPubMed
48. 1. Sala-i-Martin Xavier

    . 1997a. “I Just Ran Four Million Regressions.” NBER Working Paper 6252. Cambridge, MA.
49. 1. Sala-i-Martin Xavier

    . 1997b. “I Just Ran Two Million Regressions.” American Economic Review 87(2):178–83.

    OpenUrlWeb of Science
50. 1. Schnitzer Thomas,
    2. Hochberg Marc

    . 2002. “Cox-2-Selective Inhibitors in the Treatment of Arthritis.” Cleveland Clinic Journal of Medicine 69(1):SI20–30.

    OpenUrlAbstract/FREE Full Text
51. 1. Simons Robert,
    2. Rosenblatt Lisa,
    3. Trivedi Digisha

    . 2012. “The Economic Consequences of Rheumatoid Arthritis: Analysis of Medical Expenditure Panel Survey 2004, 2005, and 2006 Data.” Journal of Occupational and Environmental Medicine 54(1):48–55.

    OpenUrlCrossRefPubMed
52. 1. Thirumurthy Harsha,
    2. Zivin Joshua Graff,
    3. Goldstein Markus

    . 2008. “The Economic Impact of AIDS Treatment: Labor Supply in Western Kenya.” Journal of Human Resources 43(3): 511–22.

    OpenUrlAbstract/FREE Full Text
53. 1. Timbie Justin,
    2. Horvitz-Lennon Marcela,
    3. Frank Richard,
    4. Normand Sharon-Lise

    . 2006. “A Meta-Analysis of Labor Supply Effects of Interventions for Major Depressive Order.” Psychiatric Services 57(2):212–8.

    OpenUrlCrossRefPubMedWeb of Science
54. 1. Tsang Adley,
    2. Korff Michael Von,
    3. Lee Sing,
    4. Alonso Jordi,
    5. Karam Elie,
    6. Angermeyer Matthias,
    7. Borges Guilherme Luiz Guimaraes,
    8. Bromet Evelyn,
    9. Girolamo Giovanni De,
    10. Graaf Ron de,
    11. et al

    . 2008. “Common Chronic Pain Conditions in Developed and Developing Countries: Gender and Age Differences and Comorbidity with Depression-Anxiety Disorders.” Journal of Pain 9 (10):883–91.

    OpenUrlCrossRefPubMedWeb of Science
55. 1. Turk Dennis,
    2. Okifuji Akiko

    . 1999. “Assessment of Patients’ Reporting of Pain: An Integrated Perspective.” The Lancet 353(9166):1784–8.

    OpenUrl
56. 1. Weil David

    . 2007. “Accounting for the Effect of Health on Economic Growth.” The Quarterly Journal of Economics 122(3):1265–1306.

    OpenUrlCrossRefWeb of Science